APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tuberculosis Vaccines Industry Growth and Trends Forecast to 2032

Report ID 174043590120 December 2025109 pages

Choose your research edition.

Industry ResearchTuberculosis Vaccines Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Vaccines Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Tuberculosis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Tuberculosis Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tuberculosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tuberculosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tuberculosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tuberculosis Vaccines include Bavarian Nordic, China National Biotec Group, GreenSignal Bio Pharma, IDT Biologics, Japan BCG Lab, Serum Institute of India, Taj Pharmaceuticals, GlaxoSmithKline and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tuberculosis Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tuberculosis Vaccines market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tuberculosis Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tuberculosis Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tuberculosis Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tuberculosis Vaccines Market by Company

Bavarian Nordic

China National Biotec Group

GreenSignal Bio Pharma

IDT Biologics

Japan BCG Lab

Serum Institute of India

Taj Pharmaceuticals

GlaxoSmithKline

Merck

Sanofi

Tuberculosis Vaccines Segment by Type

Immunotherapeutic Vaccines

Booster Vaccines

Others

Tuberculosis Vaccines Segment by Application

Hospitals

Clinics

Others

Tuberculosis Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tuberculosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immunotherapeutic Vaccines Table 2. Major Company of Booster Vaccines Table 3. Major Company of Others Table 4. Global Tuberculosis Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tuberculosis Vaccines Sales by Type (2021-2026) & (W Units) Table 6. Global Tuberculosis Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Tuberculosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Tuberculosis Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global Tuberculosis Vaccines Price by Type (2021-2026) & (US$/Unit) Table 10. Global Tuberculosis Vaccines Sales by Type (2027-2032) & (W Units) Table 11. Global Tuberculosis Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Tuberculosis Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Tuberculosis Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global Tuberculosis Vaccines Price by Type (2027-2032) & (US$/Unit) Table 15. North America Tuberculosis Vaccines Sales by Type (2021-2026) & (W Units) Table 16. North America Tuberculosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Tuberculosis Vaccines Sales by Type (2021-2026) & (W Units) Table 18. Europe Tuberculosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Tuberculosis Vaccines Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Tuberculosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Tuberculosis Vaccines Sales by Type (2021-2026) & (W Units) Table 22. Latin America Tuberculosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Tuberculosis Vaccines Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Tuberculosis Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Tuberculosis Vaccines Industry Trends Table 26. Tuberculosis Vaccines Industry Drivers Table 27. Tuberculosis Vaccines Industry Opportunities and Challenges Table 28. Tuberculosis Vaccines Industry Restraints Table 29. Global Tuberculosis Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Tuberculosis Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global Tuberculosis Vaccines Sales by Company (2021-2026) & (W Units) Table 32. Global Tuberculosis Vaccines Sales Share by Company (2021-2026) Table 33. Global Tuberculosis Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Tuberculosis Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Tuberculosis Vaccines Major Company Production Sites and Headquarters Table 36. Global Tuberculosis Vaccines Company, Product Type & Application Table 37. Global Tuberculosis Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Tuberculosis Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Tuberculosis Vaccines Sales by Region (2021-2026) & (W Units) Table 42. Global Tuberculosis Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Tuberculosis Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Tuberculosis Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global Tuberculosis Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Tuberculosis Vaccines Sales by Region (2027-2032) & (W Units) Table 47. Global Tuberculosis Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Tuberculosis Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Tuberculosis Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global Tuberculosis Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Tuberculosis Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Tuberculosis Vaccines Sales by Application (2021-2026) & (W Units) Table 53. Global Tuberculosis Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Tuberculosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Tuberculosis Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global Tuberculosis Vaccines Price by Application (2021-2026) & (US$/Unit) Table 57. Global Tuberculosis Vaccines Sales by Application (2027-2032) & (W Units) Table 58. Global Tuberculosis Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Tuberculosis Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Tuberculosis Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global Tuberculosis Vaccines Price by Application (2027-2032) & (US$/Unit) Table 62. North America Tuberculosis Vaccines Sales by Application (2021-2026) & (W Units) Table 63. North America Tuberculosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Tuberculosis Vaccines Sales by Application (2021-2026) & (W Units) Table 65. Europe Tuberculosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Tuberculosis Vaccines Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Tuberculosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Tuberculosis Vaccines Sales by Application (2021-2026) & (W Units) Table 69. Latin America Tuberculosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Tuberculosis Vaccines Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Tuberculosis Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Bavarian Nordic Company Information Table 73. Bavarian Nordic Business Overview Table 74. Bavarian Nordic Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bavarian Nordic Tuberculosis Vaccines Product Portfolio Table 76. Bavarian Nordic Recent Development Table 77. China National Biotec Group Company Information Table 78. China National Biotec Group Business Overview Table 79. China National Biotec Group Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. China National Biotec Group Tuberculosis Vaccines Product Portfolio Table 81. China National Biotec Group Recent Development Table 82. GreenSignal Bio Pharma Company Information Table 83. GreenSignal Bio Pharma Business Overview Table 84. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolio Table 86. GreenSignal Bio Pharma Recent Development Table 87. IDT Biologics Company Information Table 88. IDT Biologics Business Overview Table 89. IDT Biologics Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. IDT Biologics Tuberculosis Vaccines Product Portfolio Table 91. IDT Biologics Recent Development Table 92. Japan BCG Lab Company Information Table 93. Japan BCG Lab Business Overview Table 94. Japan BCG Lab Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Japan BCG Lab Tuberculosis Vaccines Product Portfolio Table 96. Japan BCG Lab Recent Development Table 97. Serum Institute of India Company Information Table 98. Serum Institute of India Business Overview Table 99. Serum Institute of India Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Serum Institute of India Tuberculosis Vaccines Product Portfolio Table 101. Serum Institute of India Recent Development Table 102. Taj Pharmaceuticals Company Information Table 103. Taj Pharmaceuticals Business Overview Table 104. Taj Pharmaceuticals Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolio Table 106. Taj Pharmaceuticals Recent Development Table 107. GlaxoSmithKline Company Information Table 108. GlaxoSmithKline Business Overview Table 109. GlaxoSmithKline Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. GlaxoSmithKline Tuberculosis Vaccines Product Portfolio Table 111. GlaxoSmithKline Recent Development Table 112. Merck Company Information Table 113. Merck Business Overview Table 114. Merck Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Merck Tuberculosis Vaccines Product Portfolio Table 116. Merck Recent Development Table 117. Sanofi Company Information Table 118. Sanofi Business Overview Table 119. Sanofi Tuberculosis Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Sanofi Tuberculosis Vaccines Product Portfolio Table 121. Sanofi Recent Development Table 122. North America Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. North America Tuberculosis Vaccines Sales by Country (2021-2026) & (W Units) Table 124. North America Tuberculosis Vaccines Sales Market Share by Country (2021-2026) Table 125. North America Tuberculosis Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 126. North America Tuberculosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 127. North America Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Tuberculosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Tuberculosis Vaccines Market Share by Country (2021-2026) Table 130. North America Tuberculosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Tuberculosis Vaccines Market Share Forecast by Country (2027-2032) Table 132. Europe Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Europe Tuberculosis Vaccines Sales by Country (2021-2026) & (W Units) Table 134. Europe Tuberculosis Vaccines Sales Market Share by Country (2021-2026) Table 135. Europe Tuberculosis Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 136. Europe Tuberculosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Tuberculosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Tuberculosis Vaccines Market Share by Country (2021-2026) Table 140. Europe Tuberculosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Tuberculosis Vaccines Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Tuberculosis Vaccines Sales by Country (2021-2026) & (W Units) Table 144. Asia-Pacific Tuberculosis Vaccines Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Tuberculosis Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 146. Asia-Pacific Tuberculosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Tuberculosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Tuberculosis Vaccines Market Share by Country (2021-2026) Table 150. Asia-Pacific Tuberculosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Tuberculosis Vaccines Market Share Forecast by Country (2027-2032) Table 152. Latin America Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Latin America Tuberculosis Vaccines Sales by Country (2021-2026) & (W Units) Table 154. Latin America Tuberculosis Vaccines Sales Market Share by Country (2021-2026) Table 155. Latin America Tuberculosis Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 156. Latin America Tuberculosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Tuberculosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Tuberculosis Vaccines Market Share by Country (2021-2026) Table 160. Latin America Tuberculosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Tuberculosis Vaccines Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Tuberculosis Vaccines Sales by Country (2021-2026) & (W Units) Table 164. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Tuberculosis Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 166. Middle East and Africa Tuberculosis Vaccines Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Tuberculosis Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Tuberculosis Vaccines Market Share by Country (2021-2026) Table 170. Middle East and Africa Tuberculosis Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Tuberculosis Vaccines Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Tuberculosis Vaccines Distributors List Table 175. Tuberculosis Vaccines Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Tuberculosis Vaccines Image Figure 2. Global Tuberculosis Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Tuberculosis Vaccines Sales (2021-2032) & (W Units) Figure 5. Immunotherapeutic Vaccines Image Figure 6. Global Immunotherapeutic Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 7. Booster Vaccines Image Figure 8. Global Booster Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Tuberculosis Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Tuberculosis Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America Tuberculosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America Tuberculosis Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe Tuberculosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Tuberculosis Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Tuberculosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Tuberculosis Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Tuberculosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Tuberculosis Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Tuberculosis Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Tuberculosis Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Tuberculosis Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (W Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Tuberculosis Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Tuberculosis Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Tuberculosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Tuberculosis Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Tuberculosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Tuberculosis Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Tuberculosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Tuberculosis Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Tuberculosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Tuberculosis Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Tuberculosis Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Tuberculosis Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Tuberculosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Tuberculosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Tuberculosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tuberculosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Tuberculosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Tuberculosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tuberculosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Tuberculosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Tuberculosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tuberculosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Tuberculosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Tuberculosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tuberculosis Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Tuberculosis Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Tuberculosis Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Tuberculosis Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Tuberculosis Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Tuberculosis Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapeutic Vaccines
  • Booster Vaccines
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Bavarian Nordic
  • China National Biotec Group
  • GreenSignal Bio Pharma
  • IDT Biologics
  • Japan BCG Lab
  • Serum Institute of India
  • Taj Pharmaceuticals
  • GlaxoSmithKline
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tuberculosis Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tuberculosis Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tuberculosis Vaccines Market by Type
  6. 1.3.1 Immunotherapeutic Vaccines
  7. 1.3.2 Booster Vaccines
  8. 1.3.3 Others
  9. 1.4 Global Tuberculosis Vaccines Market Size by Type
  10. 1.4.1 Global Tuberculosis Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Tuberculosis Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Tuberculosis Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Tuberculosis Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Tuberculosis Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Tuberculosis Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Tuberculosis Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Tuberculosis Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tuberculosis Vaccines Industry Trends
  2. 2.2 Tuberculosis Vaccines Industry Drivers
  3. 2.3 Tuberculosis Vaccines Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tuberculosis Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Tuberculosis Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Tuberculosis Vaccines Price (2021-2026)
  4. 3.4 Global Tuberculosis Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tuberculosis Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Tuberculosis Vaccines Company, Product Type & Application
  7. 3.7 Global Tuberculosis Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tuberculosis Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tuberculosis Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tuberculosis Vaccines Tier 1, Tier 2, and Tier 3
4 Tuberculosis Vaccines Regional Status and Outlook
  1. 4.1 Global Tuberculosis Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tuberculosis Vaccines Historic Market Size by Region
  3. 4.2.1 Global Tuberculosis Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tuberculosis Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tuberculosis Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tuberculosis Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Tuberculosis Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tuberculosis Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tuberculosis Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tuberculosis Vaccines by Application
  1. 5.1 Tuberculosis Vaccines Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Tuberculosis Vaccines Market Size by Application
  6. 5.2.1 Global Tuberculosis Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tuberculosis Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tuberculosis Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tuberculosis Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tuberculosis Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tuberculosis Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tuberculosis Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tuberculosis Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bavarian Nordic
  2. 6.1.1 Bavarian Nordic Company Information
  3. 6.1.2 Bavarian Nordic Business Overview
  4. 6.1.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bavarian Nordic Tuberculosis Vaccines Product Portfolio
  6. 6.1.5 Bavarian Nordic Recent Developments
  7. 6.2 China National Biotec Group
  8. 6.2.1 China National Biotec Group Company Information
  9. 6.2.2 China National Biotec Group Business Overview
  10. 6.2.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 China National Biotec Group Tuberculosis Vaccines Product Portfolio
  12. 6.2.5 China National Biotec Group Recent Developments
  13. 6.3 GreenSignal Bio Pharma
  14. 6.3.1 GreenSignal Bio Pharma Company Information
  15. 6.3.2 GreenSignal Bio Pharma Business Overview
  16. 6.3.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolio
  18. 6.3.5 GreenSignal Bio Pharma Recent Developments
  19. 6.4 IDT Biologics
  20. 6.4.1 IDT Biologics Company Information
  21. 6.4.2 IDT Biologics Business Overview
  22. 6.4.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 IDT Biologics Tuberculosis Vaccines Product Portfolio
  24. 6.4.5 IDT Biologics Recent Developments
  25. 6.5 Japan BCG Lab
  26. 6.5.1 Japan BCG Lab Company Information
  27. 6.5.2 Japan BCG Lab Business Overview
  28. 6.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Japan BCG Lab Tuberculosis Vaccines Product Portfolio
  30. 6.5.5 Japan BCG Lab Recent Developments
  31. 6.6 Serum Institute of India
  32. 6.6.1 Serum Institute of India Company Information
  33. 6.6.2 Serum Institute of India Business Overview
  34. 6.6.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Serum Institute of India Tuberculosis Vaccines Product Portfolio
  36. 6.6.5 Serum Institute of India Recent Developments
  37. 6.7 Taj Pharmaceuticals
  38. 6.7.1 Taj Pharmaceuticals Company Information
  39. 6.7.2 Taj Pharmaceuticals Business Overview
  40. 6.7.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolio
  42. 6.7.5 Taj Pharmaceuticals Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Tuberculosis Vaccines Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Merck
  50. 6.9.1 Merck Company Information
  51. 6.9.2 Merck Business Overview
  52. 6.9.3 Merck Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Tuberculosis Vaccines Product Portfolio
  54. 6.9.5 Merck Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Tuberculosis Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Tuberculosis Vaccines Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Tuberculosis Vaccines Sales by Country
  2. 7.1.1 North America Tuberculosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tuberculosis Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Tuberculosis Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tuberculosis Vaccines Market Size by Country
  6. 7.2.1 North America Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tuberculosis Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Tuberculosis Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tuberculosis Vaccines Sales by Country
  2. 8.1.1 Europe Tuberculosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tuberculosis Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Tuberculosis Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tuberculosis Vaccines Market Size by Country
  6. 8.2.1 Europe Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tuberculosis Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tuberculosis Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tuberculosis Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Tuberculosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tuberculosis Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tuberculosis Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tuberculosis Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tuberculosis Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tuberculosis Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tuberculosis Vaccines Sales by Country
  2. 10.1.1 South America Tuberculosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tuberculosis Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Tuberculosis Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tuberculosis Vaccines Market Size by Country
  6. 10.2.1 South America Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tuberculosis Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Tuberculosis Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tuberculosis Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Tuberculosis Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tuberculosis Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tuberculosis Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tuberculosis Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tuberculosis Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tuberculosis Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tuberculosis Vaccines Value Chain Analysis
  2. 12.1.1 Tuberculosis Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tuberculosis Vaccines Production Mode & Process
  7. 12.2 Tuberculosis Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tuberculosis Vaccines Distributors
  10. 12.2.3 Tuberculosis Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst